Software Healthcare Sector

Agilent Technologies

Market Cap: US$39.2b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

IQVIA Holdings

Market Cap: US$39.1b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Natera

Market Cap: US$38.6b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Waters

Market Cap: US$37.3b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

BeOne Medicines

Market Cap: US$35.8b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Royalty Pharma

Market Cap: US$33.6b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Veeva Systems

Market Cap: US$32.7b

Provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.

Zoetis

Market Cap: US$31.9b

Engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.

GE HealthCare Technologies

Market Cap: US$31.6b

Engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.

Illumina

Market Cap: US$31.0b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Biogen

Market Cap: US$30.7b

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally.

ResMed

Market Cap: US$30.1b

Develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally.

Centene

Market Cap: US$30.1b

Operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.

Mettler-Toledo International

Market Cap: US$28.4b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

DexCom

Market Cap: US$28.1b

A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally.

Alnylam Pharmaceuticals

Market Cap: US$27.5b

Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.

Quest Diagnostics

Market Cap: US$25.9b

Provides diagnostic testing and services in the United States.

Labcorp Holdings

Market Cap: US$25.5b

Provides laboratory services.

Incyte

Market Cap: US$24.9b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Roivant Sciences

Market Cap: US$24.8b

A clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

West Pharmaceutical Services

Market Cap: US$23.9b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Sigma Healthcare

Market Cap: AU$33.8b

Operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia.

BioNTech

Market Cap: US$23.5b

Engages in the development and commercialization of immunotherapies in Germany.

Moderna

Market Cap: US$23.0b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

STERIS

Market Cap: US$22.5b

Provides infection prevention products and services in the United States, Ireland, and internationally.

Insmed

Market Cap: US$22.0b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

United Therapeutics

Market Cap: US$22.0b

Engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Viatris

Market Cap: US$20.7b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Guardant Health

Market Cap: US$20.4b

A precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally.

Tenet Healthcare

Market Cap: US$20.3b

Operates as a diversified healthcare services company in the United States.

Zimmer Biomet Holdings

Market Cap: US$18.4b

Operates as a medical technology company worldwide.

Neurocrine Biosciences

Market Cap: US$17.0b

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.

Ascendis Pharma

Market Cap: US$16.6b

Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.

Jazz Pharmaceuticals

Market Cap: US$16.2b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

Medpace Holdings

Market Cap: US$16.1b

Provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia.

BridgeBio Pharma

Market Cap: US$16.1b

A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.